News from
Chemistry Of Creativity
2025-05-17 17:45:03| Spiritual Career Counseling
Massachusetts Institute of Technology Senior Madison Wang, a double major in creative writing and chemistry , developed her passion for writing in middle school. Her interest in chemistry fit nicely alongside her commitment to producing engaging narratives.Wang believes that world-building in stories supported by science and research can make for a more immersive reader experience."In science and in writing, you have to tell an effective story," she says. "People respond well to stories."A native of Buffalo, New York, Wang applied early action for admission to MIT and learned quickly that the Institute was where she wanted to be. "It was a really good fit," she says. "There was positive energy and vibes, and I had a great feeling overall."The power of science and good storytelling"Chemistry is practical, complex, and interesting," says Wang. "It's about quantifying natural laws and understanding how reality works."Chemistry and writing both help us "see the world's irregularity," she c...
Category:
Employment
LATEST NEWS
7 IoT Security Issues and How To Prevent Them
2025-05-17 15:45:04| Spiritual Career Counseling
Internet of things (IoT) security issues are vulnerabilities that can be exploited in the interconnected network of devices. These problems can lead to potential data breaches and identity theft. As the IoT market grows, its becoming increasingly crucial to ensure robust security to continually protect sensitive information.Lets uncover the seven biggest IoT security issues currently jeopardizing these systems everywhere. Our experts also share the best practices to address these challenges.Table of ContentsTop 7 Internet of Things Security IssuesIoT Security SolutionsOther IoT Security Best PracticesThe Future of Internet of Things Security: How Will IoT Evolve in 2025?IoT Security Issues TakeawaysIoT Security FAQsTop 7 Internet of Things Security IssuesFrom hijacking of IoT devices and potential home invasions to dangers of rogue devices, these are the seven most serious internet of things security concerns that IoT expertssingle out.Ransomware and Hijacking of IoT DevicesInsuffici...
Category:
Employment
Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases
2025-05-17 15:45:04| Spiritual Career Counseling
April 08, 2025 08:00 ET | Source: Opus Genetics, Inc. First pediatric patient shows encouraging early safety profile and meaningful improvement in visual function at one month A second pediatric patient was recently dosed, and the pediatric cohort is expected to complete enrollment in Q2 2025; initial data from all three patients anticipated in Q3 2025 FDA Type D meeting provided clarity on next steps for a registrational trial design to support BLA submission, with potential trial initiation in 2026 DURHAM, N.C., April 08, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and to treat other ophthalmic disorders (Opus or the Company), today announced one-month clinical data from the first pediatric patient treated with its investigational gene therapy, OPGx-LCA5, in a Phase 1/2 open-label trial for LCA5-related inherited retinal disease (IRD)....
Category:
Employment